“Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta” (2025) Life and Science, 6(4), p. 06. doi:10.37185/LnS.1.1.870.